Bradley Glover
Direttore operativo presso IMUGENE LIMITED
Patrimonio netto: 109 220 $ in data 31/05/2024
Profilo
Bradley Glover is currently the Chief Operating Officer at Imugene Ltd.
He previously worked as the Vice President of Corporate Development at Kite Pharma, Inc. and as the Chief Technology Officer and Executive Vice President at Celularity, Inc. (United States).
He also served as the Chief Operating Officer and Executive Vice President at Celularity, Inc. from 2021 to 2023.
Dr. Glover received his undergraduate degree from the University of California San Diego, his doctorate from the University of Colorado, and his MBA from the Rady School of Management at UC San Diego.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CELULARITY INC. CLASS A
0.16% | 13/04/2023 | 35 119 ( 0.16% ) | 109 220 $ | 31/05/2024 |
Posizioni attive di Bradley Glover
| Società | Posizione | Inizio |
|---|---|---|
| IMUGENE LIMITED | Direttore operativo | 21/08/2023 |
Precedenti posizioni note di Bradley Glover
| Società | Posizione | Fine |
|---|---|---|
| CELULARITY INC. | Direttore operativo | 31/05/2023 |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Direttore Tecnico/Scientifico/R&S | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Formazione di Bradley Glover
| The University of Colorado | Doctorate Degree |
| Rady School of Management at UC San Diego | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CELULARITY INC. | Commercial Services |
| IMUGENE LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Commercial Services |
- Borsa valori
- Insiders
- Bradley Glover
